Riboflavin-mediated corneal crosslinking
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Riboflavin-mediated corneal crosslinking, covering 2013-01-17 to 2013-01-17. Get the full timeline:
Most recent: Clinical Trial Update: Riboflavin Mediated Corneal Crosslinking for Stabilizing Progression of Keratoconus [Phase 2, Phase 3]